FY26 Results: PAT Jumps 50%, Dividend of ₹20/Share Recommended
Gland Pharma Limited · GLAND · NSE ·
<b>Stellar Profit Growth:</b> Consolidated Profit After Tax (PAT) surged <b>50% YoY</b> to ₹10,455 Mn for FY26, with revenue growing 14% to ₹64,307 Mn. <b>Shareholder Payout:</b> The Board has recommended a final dividend of <b>₹20 per equity share</b> for the fiscal year 2026. <…